← Open Payments lookup

ERIC ZYWICKI: Open Payments

NPI 1851801443 · SAN BERNARDINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,244 in 100 payments from 13 companies in 2025. Trend: 2023 $1,294 · 2024 $951 · 2025 $2,244

Food & beverage: $2,244
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.11$310
E.R. Squibb & Sons, L.L.C.10$308
Axsome Therapeutics, Inc.10$281
Janssen Pharmaceuticals, Inc11$273
Otsuka America Pharmaceutical, Inc.13$265
Alkermes, Inc.14$240
Tris Pharma Inc9$178
Lundbeck LLC11$138
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$83
Teva Pharmaceuticals USA, Inc.3$65

Products named: COBENFY, Auvelity, REXULTI, FANAPT, ARISTADA, INVEGA SUSTENNA, SPRAVATO, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.